Skip to main content
$2.81 $0.04 (1.4%)

04:00 PM EDT on 07/01/22

Affimed Therapeutics (NASDAQ:AFMD)

CAPS Rating: 1 out of 5

Current Price $2.81 Mkt Cap $419.5M
Open $2.79 P/E Ratio 0.00
Prev. Close $2.81 Div. (Yield) $0.00 (0.0%)
Daily Range $2.73 - $2.86 Volume 448,288
52-Wk Range $2.23 - $7.39 Avg. Daily Vol. 1,407,192

Caps

How do you think NASDAQ:AFMD will perform against the market?

Add Stock to CAPS Watchlist

All Players

56 Outperform
10 Underperform
 

All-Star Players

19 Outperform
8 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AFMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.77)
Submitted January 15, 2015

Affimed is another leap of faith stock for me, in that I made my initial trades in the stock purely on Portefeuille's instructions and currently have 1500 shares with a cost basis of 6. I finally got around to reviewing the stock today and so far I'm… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:AFMD Summary

Fools bearish on NASDAQ:AFMD are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AFMD.

Recs

0
Member Avatar hepanefc (68.55) Submitted: 1/21/2022 12:14:07 PM : Underperform Start Price: $4.35 NASDAQ:AFMD Score: +19.28

Most Recent Picks

Recs

0
Member Avatar Car12703 (< 20) Submitted: 9/28/2021 9:51:50 AM : Outperform Start Price: $6.11 NASDAQ:AFMD Score: -41.29

From Fidelity or Zacks September 2021:
Revenue Growth (Last 5 Years) = 33.0%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 262.1%
Price/Sales (TTM) = 15.9

Recs

3
Member Avatar zzlangerhans (99.77) Submitted: 1/15/2015 1:20:17 AM : Outperform Start Price: $6.01 NASDAQ:AFMD Score: -143.94

Affimed is another leap of faith stock for me, in that I made my initial trades in the stock purely on Portefeuille's instructions and currently have 1500 shares with a cost basis of 6. I finally got around to reviewing the stock today and so far I'm pretty happy with the position. Affimed is developing bispecific antibodies, which was a very productive platform for Micromet before they were bought out by Amgen for a significant premium in 2012. Affimed's lead compound, AFM13 for relapsed/refractory Hodgkin's and CTCL, should begin a phase IIa trial in the near future.

Affimed hasn't garnered much love since their 2014 IPO, actually closing below their IPO price on the first day of trading. I can't remember the last time I saw that happen for an oncology biotech IPO. Perhaps there's something to the market's skepticism - I haven't been a very good judge of cheap bios with proprietary platforms recently. On the other hand, Affimed's base in Heidelberg makes them well-suited to be followed by Portefeuille. European-based biopharmas are often neglected by US based traders, even when they trade on US exchanges. There's clearly much more to be learned about Affimed but zzporte is already in the green thanks to a couple of timely trades so for now I'm happy to be along for the ride.

Leaderboard

Find the members with the highest scoring picks in AFMD.

Score Leader

TheTork

TheTork (67.73) Score: +199.74

The Score Leader is the player with the highest score across all their picks in AFMD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
BobbyCyclone 27.64 3/10/2015 Underperform 5Y $6.06 -53.80% +85.06% +138.85 0 Comment
Under5 45.30 1/9/2018 5/25/2022 Outperform 5Y $1.28 +119.61% +38.72% +80.89 0 Comment
NobleOrSomeBull 99.83 7/6/2016 Underperform 5Y $2.74 +2.19% +82.16% +79.97 0 Comment
anchak 99.92 8/28/2018 Underperform NS $5.00 -44.00% +31.53% +75.53 0 Comment
BigCaps18 94.77 12/23/2020 Underperform 5Y $6.70 -58.21% +3.54% +61.75 0 Comment
AtlanticoClub 86.26 7/24/2020 Underperform 5Y $4.12 -32.04% +18.98% +51.02 0 Comment
ak1010 99.89 2/1/2018 Outperform 5Y $1.70 +64.71% +35.33% +29.38 0 Comment
hepanefc 68.55 1/19/2022 2/7/2022 Underperform 3M $4.35 -35.56% -16.27% +19.28 1 Comment
jon5555 94.29 1/19/2022 Underperform 5Y $4.25 -34.12% -16.77% +17.35 0 Comment
PAGEBOY73 98.53 5/16/2022 Underperform 3W $3.24 -13.58% -4.67% +8.92 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AFMD.